APA (7th ed.) Citation

Fagiuoli S, Toniutto P, Coppola N, Ancona DD, Andretta M, Bartolini F, . . . Mangia A. (2023). Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Dove Medical Press.

Chicago Style (17th ed.) Citation

Fagiuoli S, et al. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Dove Medical Press, 2023.

MLA (9th ed.) Citation

Fagiuoli S, et al. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Dove Medical Press, 2023.